Women’s Health Funding Cuts in 2025
What: Maternie’s roundup of funding cuts includes the WHI (now reversed), PRAMS, ART Surveillance, and Title X. Updated regularly.
Key Line: “To submit any tips on funding cuts, fill out our form here.”
Marty Makary faces controversies as the new FDA commissioner.
Women who start menopause before age 40 may face faster cognitive decline.
Cancer incidence among women continues to rise despite overall progress.
Breast pump startup Willow takes over UK-based Elvie’s assets, signaling tough market conditions for women’s health companies.
Maternie’s live tracker outlines federal program cuts, including Title X and IVF teams.
Mouse study reveals female hormones help trigger opioid production in spinal cord immune cells.
Estrogen’s role in the brain goes far beyond reproduction, NYT reports.
Science reports the entire CDC team behind contraceptive safety guidelines has been ousted.
JAMA editorial calls for uniform lactation training among healthcare workers.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
A major study ties maternal diabetes to neurodevelopmental issues in children.
A New York clerk blocked a Texas court filing targeting a doctor who provided abortion pills.
Hormone therapy may lower a genetic heart risk factor, new WHI data suggests.
Science reports the entire CDC team behind contraceptive safety guidelines has been ousted.
Women’s health startups raised $2.6B in VC funding last year, but exits remain elusive.
Study finds no mass OBGYN flight from states with abortion bans—yet.
The Trump administration ends the Pregnancy Risk Assessment Monitoring System (PRAMS), a long-standing CDC data tool.
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
Over a dozen states are considering bills to expand menopause care and insurance coverage.
Interleukin-6 shows early promise in detecting life-threatening sepsis.